Cells as delivery vehicles for cancer therapeutics
dc.citation.doi | doi:10.4155/tde.14.24 | en_US |
dc.citation.epage | 567 | en_US |
dc.citation.issue | 5 | en_US |
dc.citation.jtitle | Therapeutic Delivery | en_US |
dc.citation.spage | 555 | en_US |
dc.citation.volume | 5 | en_US |
dc.contributor.author | Basel, Matthew T. | |
dc.contributor.author | Shrestha, Tej Bahadur | |
dc.contributor.author | Bossmann, Stefan H. | |
dc.contributor.author | Troyer, Deryl L. | |
dc.contributor.authoreid | mbasel | en_US |
dc.contributor.authoreid | tbs3 | en_US |
dc.contributor.authoreid | sbossman | en_US |
dc.contributor.authoreid | troyer | en_US |
dc.date.accessioned | 2014-11-14T17:18:53Z | |
dc.date.available | 2014-11-14T17:18:53Z | |
dc.date.issued | 2014-11-14 | |
dc.date.published | 2014 | en_US |
dc.description.abstract | Cell-based therapeutics have advanced significantly over the past decade and are poised to become a major pillar of modern medicine. Three cell types in particular have been studied in detail for their ability to home to tumors and to deliver a variety of different payloads. Neural stem cells, mesenchymal stem cells and monocytes have each been shown to have great potential as future delivery systems for cancer therapy. A variety of other cell types have also been studied. These results demonstrate that the field of cell-based therapeutics will only continue to grow. | en_US |
dc.identifier.uri | http://hdl.handle.net/2097/18675 | |
dc.language.iso | en_US | en_US |
dc.relation.uri | http://www.future-science.com/doi/abs/10.4155/tde.14.24 | en_US |
dc.subject | Tumor tropism | en_US |
dc.subject | Chemotaxis | en_US |
dc.subject | Magnetic hyperthermia | en_US |
dc.subject | Cellābased gene therapy | en_US |
dc.subject | Suicide gene | en_US |
dc.subject | Cancer therapies | en_US |
dc.title | Cells as delivery vehicles for cancer therapeutics | en_US |
dc.type | Article (author version) | en_US |